Nature Cell to Establish $4M Stem Cell Manufacturing Facility in Baltimore, Creating 500 Jobs
Key Insights
Korean biotechnology company Nature Cell (search) is establishing a 100,000 square-foot stem cell manufacturing facility in Baltimore, bringing an estimated 500 new full-time jobs to the region by 2031.
The facility will focus on knee osteoarthritis (search) and Alzheimer's (search) stem cell research, clinical trials, and manufacturing investigational products, with plans to produce one million doses annually of JointStem (search), an intra-articular stem cell injection.
Maryland is providing $4 million in conditional loans through the Department of Commerce, while Baltimore Development Corporation (search) is contributing $400,000 to support the project and expedite regulatory approvals.
Korean biotechnology company Nature Cell (search) announced plans to establish a major stem cell manufacturing facility in Baltimore, representing a significant investment in Maryland's life sciences sector. The company will create an estimated 500 new full-time jobs through a 100,000 square-foot operation at 1401 Severn Street in the mixed-use Gaslight Square complex.
Manufacturing Focus and Production Goals
The facility will be operated by Nature Cell America (search), a subsidiary that plans to initially focus on knee osteoarthritis (search) and Alzheimer's (search) stem cell research, clinical trials, and manufacturing investigational products. With expanded capacity for stem cell therapy research and development, the company aims to produce an estimated one million doses of its product JointStem (search), an intra-articular stem cell injection, per year.
Nature Cell (search)'s business encompasses stem cells, cosmetics, and food and beverage development and manufacturing. The company will work jointly with Biostar (search), a Korean holding company that leads in stem cell technology, on this new subsidiary project.
Strategic Location Selection
Nature Cell (search) Chairman Dr. Jeong-Chan Ra emphasized the comprehensive evaluation that led to Maryland's selection. "We have chosen Maryland for the site of the Nature Cell Biostar (search) USA Stem Cell Campus after a comprehensive evaluation of the state's exceptional ecosystem for our business," Ra said. "Maryland offers an abundant pool of highly-skilled technical talent that is critical to establishing global leadership and setting industry standards in stem cell therapeutics."
The company specifically cited the Maryland Stem Cell Research Fund and the state's life sciences workforce as key factors for choosing to locate in Maryland. Ra also highlighted the region's collaborative industry and academic network, noting that "world-class institutions such as Johns Hopkins University School of Medicine and its affiliated hospitals, are central to advancing stem cell research and development."
Financial Support and Development Timeline
The Maryland Department of Commerce (search) is working to approve a $4 million conditional loan through Advantage Maryland to assist with project costs. Additionally, the Baltimore Development Corporation (search) is providing a $400,000 conditional loan to assist the company with its operations, while Baltimore City will help expedite permitting and public approvals for the project.
The facility will be completed in two phases through 2031, establishing Nature Cell (search)'s significant presence in the U.S. market while contributing to Baltimore's growing biotechnology sector.
Economic Impact and Industry Significance
Governor Wes Moore emphasized the investment's broader implications for Maryland's biotechnology leadership. "Maryland continues to lead in life sciences innovation and Nature Cell (search)'s investment reinforces our reputation as a global hub for biotechnology and advanced research," Moore stated. "We are pleased that Maryland's talent and resources continue to help attract international companies like Nature Cell to the U.S. while also creating hundreds of high-quality jobs in Baltimore."
Baltimore Mayor Brandon Scott highlighted the project's role in connecting the city's manufacturing heritage with its expanding life sciences sector. "Nature Cell (search)'s decision to bring cutting-edge innovation to one of our city's historic industrial sites shows what's possible when we connect our legacy of manufacturing strength with our growing life sciences sector," Scott said.
The facility represents a significant addition to the Carroll-Camden Industrial Area and demonstrates the collaborative approach between state and city governments in attracting biotechnology investments to the region.